Noul Co., Ltd., a leading medical AI company, has published its fourth annual Sustainability Report, highlighting its commitment to corporate social responsibility and sustainable business practices. The report details the company’s achievements in improving access to healthcare, particularly through its malaria diagnostic product, miLabTM MAL, which was introduced in 19 countries in 2023. Noul also outlines its Five Sustainability Focus Areas and its Implementation Strategy for achieving them over the next three years.